The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No ClinVar Id was directly found from the curated document
  • No CSPEC related information was provided by the message!

  • No Criteria Specification was provided in the publication event for the variant classifaction.
  • The Criteria Specification shown below is a best-estimate based on the VCEP, gene, disease, and publication date.

Variant: NM_001142805.2:c.1391A>G

CA415087450

Gene: SLC6A8 (HGNC:6535)
Condition: creatine transporter deficiency (MONDO:0010305)
Inheritance Mode: X-linked inheritance
UUID: 152785aa-baf5-4eb0-8811-155c7ee159f5
Approved on: 2023-08-07
Published on: 2023-08-24

HGVS expressions

NM_001142805.2:c.1391A>G
NC_000023.11:g.153694372A>G
CM000685.2:g.153694372A>G
NC_000023.10:g.152959827A>G
CM000685.1:g.152959827A>G
NC_000023.9:g.152613021A>G
NG_012016.1:g.11076A>G
NG_012016.2:g.11076A>G
ENST00000253122.10:c.1421A>G
ENST00000253122.9:c.1421A>G
ENST00000413787.1:c.350A>G
ENST00000430077.6:c.1076A>G
ENST00000442457.1:c.475A>G
ENST00000485324.1:n.1642A>G
NM_001142805.1:c.1391A>G
NM_001142806.1:c.1076A>G
NM_005629.3:c.1421A>G
NM_005629.4:c.1421A>G
More

Likely Pathogenic

Met criteria codes 3
PP4_Strong PP3 PM2_Supporting
Not Met criteria codes 1
PS4

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Cerebral Creatine Deficiency Syndromes VCEP
The NM_005629.4:c.1421A>G variant in SLC6A8 is a missense variant that is predicted to result in the substitution of aspartate by glycine at amino acid 474 (p.Asp474Gly). This variant has been reported in one (hemizygous) male proband with mild intellectual disability, elevated urine creatine/creatinine, and absent creatine peak on brain MRS (PMID: 29435807) (PP4_Strong). The variant is absent in gnomAD v2.1.1. (PM2_Supporting). The computational predictor REVEL gives a score of 0.971 which is above the threshold of 0.75, evidence that correlates with impact to SLC6A8 function (PP3). There is no ClinVar entry for this variant. In summary, this variant meets criteria to be classified as likely pathogenic for creatine transporter deficiency. SLC6A8-specific criteria applied, as specified by the ClinGen CCDS VCEP (Specifications Version 1.1.0): PP4_Strong, PP3, PM2_Supporting. (Classification approved by the ClinGen CCDS VCEP, August 7, 2023)
Met criteria codes
PP4_Strong
PMID: 29435807: 1 hemizygous male proband with elevated urine creatine/creatinine; absent creatine peak on brain MRS w/full SLC6A8 gene sequencing (PP4_Strong)
PP3
The computational predictor REVEL gives a score of 0.971 which is above the threshold of 0.75, evidence that correlates with impact to SLC6A8 function (PP3).
PM2_Supporting
The variant is absent in gnomAD v2.1.1. (PM2_Supporting).
Not Met criteria codes
PS4
Patient 3: 4y M w/Mild ID, occasional febrile seizures; not counted for PS4 as proband counted for PP4 ( PMID: 29435807)
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.